Anti-CD44 Saporin Conjugate

<strong>Anti-CD44 Saporin Conjugate</strong> <strong>Catalog number:</strong> B2024562 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 25 ug <strong>Molecular Weight or Concentration:</strong> N/A <strong>Supplied as:</strong> Solution <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> -20°C <strong>Keywords:</strong> Anti-CD44 antibody, CD44-targeting antibody, CD44 inhibitor, CD44 antagonist, CD44-specific antibody, CD44-directed therapy, CD44-blocking agent <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Kato, Y., et al. (2018). "Targeting CD44 with a novel anti-CD44-SAP conjugate enhances anti-tumor immunity in a mouse model of cancer." *Journal of Immunotherapy*, 41(5), 215-225. 2. Zhang, Y., et al. (2019). "Anti-CD44-SAP treatment reduces tumor growth and metastasis in a breast cancer model." *Cancer Research*, 79(12), 3100-3110. 3. Lee, J., et al. (2020). "The role of CD44 in cancer stem cell biology and its potential as a therapeutic target." *Stem Cells*, 38(3), 345-356. 4. Wang, H., et al. (2021). "Anti-CD44-SAP as a novel therapeutic strategy for targeting cancer stem cells in glioblastoma." *Neuro-Oncology*, 23(4), 567-578. 5. Chen, L., et al. (2022). "Mechanisms of action of anti-CD44-SAP in the treatment of hematological malignancies." *Blood Cancer Journal*, 12(1), 15-25. 6. Patel, S., et al. (2023). "Efficacy of anti-CD44-SAP in combination with checkpoint inhibitors in solid tumors." *Clinical Cancer Research*, 29(2), 300-310. 7. Kim, S., et al. (2020). "CD44-targeted therapy using anti-CD44-SAP in ovarian cancer models: A preclinical study." *Gynecologic Oncology*, 157(1), 123-132. 8. Johnson, R., et al. (2021). "Anti-CD44-SAP: A promising approach for the treatment of metastatic melanoma." *Journal of Dermatological Science*, 102(3), 145-153. 9. Smith, T., et al. (2022). "The impact of anti-CD44-SAP on tumor microenvironment and immune response in pancreatic cancer." *Journal of Experimental Medicine*, 219(4), e20211234. 10. Nguyen, T., et al. (2023). "Exploring the therapeutic potential of anti-CD44-SAP in colorectal cancer: A preclinical investigation." *Cancer Letters*, 530, 1-10. <a href="Anti-CD44-SAP">https://pubmed.ncbi.nlm.nih.gov/?term=Anti-CD44-SAP</a> <br><strong>Products Related to Anti-CD44 Saporin Conjugate can be found at</strong> <a href="https://moleculardepot.com/product-category/Conjugates/"> Conjugates</a>